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Abstract 
Purpose: To verify the accuracy of an infrared (IR) marker-based dynamic tumor-tracking 
irradiation system (IR Tracking) using the gimbaled x-ray head of the Vero4DRT 35 
(MHI-TM2000). 
Methods and Materials: The gimbaled 6-MV C-band x-ray head of the Vero4DRT can 
swing along the pan-and-tilt direction to track a moving target. During beam delivery, the 
Vero4DRT predicts the future three-dimensional (3D) target position in real time using a 
correlation model (4D model) between the target and IR marker motion, and then 40 
continuously transfers the corresponding tracking orientation to the gimbaled x-ray head. The 
4D-modeling error (E4DM) and the positional tracking error (EP) were defined as the 
difference between the predicted and measured positions of the target in 4D modeling and as 
the difference between the tracked and measured positions of the target during irradiation, 
respectively. For the clinical application of IR Tracking, we assessed the relationship between 45 
E4DM and EP for three 1D sinusoidal (peak-to-peak amplitude [A]: 20-40 mm, breathing 
period [T]: 2-4 s), five 1D phase-shifted sinusoidal (A: 20 mm, T: 4 s, phase shift [τ]: 0.2-2 s), 
and six 3D patient respiratory patterns. 
Results: The difference between the 95th percentile of the absolute EP ( 95PE ) and the mean (μ) 
+ two standard deviations (SD) of absolute E4DM ( SDDME
2μ
4
+ ) was within ±1 mm for all motion 50 
patterns. As the absolute correlation between the target and IR marker motions decreased from 
1.0 to 0.1 for the 1D phase-shifted sinusoidal patterns, the SDDME
2μ
4
+  and 95PE  increased linearly, 
from 0.4 to 3.0 mm (R = -0.98) and from 0.5 to 2.2 mm (R = -0.95), respectively. There was a 
strong positive correlation between SDDME
2μ
4
+  and 95PE  in each direction [(lateral, craniocaudal, 
anteroposterior) = (0.99, 0.98, 1.00)], even for the 3D respiratory patterns; thus, 95PE  was 55 




Conclusions: Positional tracking errors correlated strongly with 4D-modeling errors in IR 
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Tracking. Thus, the accuracy of the 4D model must be verified before treatment, and margins 
are required to compensate for the 4D-modeling error. 
 60 
Key words: Four-dimensional image-guided radiotherapy, dynamic tumor-tracking 
irradiation, intrafractional respiratory motion, gimbaled x-ray head, tracking accuracy. 
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I. INTRODUCTION 
The International Commission on Radiation Units and Measurements (ICRU) 65 
recommends that the planning target volume (PTV) includes margins around a clinical target 
volume (CTV) to account for patient motion, tumor motion, and deformation due to 
respiration and uncertainties in beam placement.1,2 Particularly for thoracic and abdominal 
tumors, respiration is an important factor causing uncertainty during beam delivery. Several 
techniques, including respiratory gating, breath-holding, and dynamic tumor tracking (DTT), 70 
have been proposed to reduce the uncertainties caused by respiratory motion.3 Among these 
techniques, DTT can minimize the internal uncertainties without a prolonged treatment time 
or the burden of breath-holding for patients. There are two approaches to DTT: direct and 
indirect methods.3,4 While direct methods detect the target itself, indirect methods assess 
some surrogate quantity and deduce localization information based on the surrogate. 75 
We have developed a novel four-dimensional (4D) image-guided radiotherapy system 
with a DTT function: the Vero4DRT (MHI-TM2000; Mitsubishi Heavy Industries, Ltd., Japan, 
and BrainLAB, Feldkirchen, Germany).5-11 Figure 1 shows a schematic diagram of the 
Vero4DRT. The Vero4DRT has several unique components that facilitate DTT irradiation: (1) 
a compact C-band 6-MV x-ray head with a gimbal mechanism, mounted on an O-ring gantry. 80 
The gimbaled x-ray head can rotate in both the pan (horizontal to the O-ring) and tilt (vertical 
to the O-ring) directions, (2) a gantry-mounted orthogonal kV x-ray imaging subsystem, 
consisting of two sets of x-ray tubes and flat-panel detectors, with a spatial resolution of 0.2 
mm at the isocenter level, and (3) an extended version of the ExacTRAC system for the DTT 
function (BrainLAB)12,13 with an infrared (IR) camera mounted on the ceiling of the treatment 85 
room.  
The Vero4DRT is capable of direct and indirect DTT approaches. One is an x-ray 
image-based direct DTT approach (X-ray Tracking).9,10 A moving tumor is tracked in real time 
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by either direct monitoring of the tumor itself or fiducial markers, using the kV x-ray imaging 
subsystem. However, the x-ray monitoring interval and image processing time delay cause 90 
prediction errors.10 Furthermore, continuous x-ray monitoring may result in two potential 
health hazards: deterministic and stochastic risks associated with the increased radiation dose 
delivered by the kV x-ray imaging subsystem.14-17 The other is an IR marker-based indirect 
DTT approach (IR Tracking), which is available clinically. An advantage of IR Tracking is a 
substantial reduction in imaging dose, compared with that of X-ray Tracking. During beam 95 
delivery, the Vero4DRT monitors the displacement of the IR markers on the abdominal wall 
continuously via the IR camera of the ExacTRAC system, and then tracks target motion using a 
correlation model (4D model) between the target and IR marker motions, as described in 
Section II. A. 
A key issue in indirect DTT is the accuracy of the model predicting the internal target 100 
position based on the surrogate measurements.3,4 Several investigators have shown that the 
Synchrony Respiratory Tracking System, part of the Cyberknife indirect DTT system 
(Accuracy Inc., Sunnyvale, CA), was able to follow a moving tumor with high accuracy.18-22 
Depuydt et al. verified the positional tracking accuracy of IR Tracking only under conditions of 
a perfect correlation between the target and IR marker motions using a prototype of the 105 
Vero4DRT;13 however, no dosimetric verification was performed. According to the report of 
the American Association of Physicists in Medicine Task Group 76, phase shifts between the 
internal tumor and external surrogate motion of > 1 s were observed in patients with lung 
cancer.3 The accuracy of a 4D model is unknown in the presence of such a phase shift. 
Additionally, tracking accuracy – based on the respiratory tumor and abdominal wall motions 110 
of real patients – should be verified before the clinical use of IR Tracking. Thus, in the present 
study, we verified the dosimetric and positional accuracy of IR Tracking. 
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II. MATERIALS AND METHODS 115 
II. A. The 4D model for IR Tracking with the Vero4DRT 
Figure 2 shows a schematic diagram of IR Tracking. Before irradiation, IR marker 
displacements on the abdominal wall and the implanted fiducial markers’ motion are 
monitored to create a 4D model for 20-40 s using the IR camera of the ExacTRAC system 
every 16.7 ms and the orthogonal kV x-ray imaging subsystem every 80 ms, using a 120 
stereovision technique. After monitoring, two target positions are determined: the detected 
target position and the predicted target position. The detected target position is indicated by the 
centroid of the polyhedron, composed from the implanted fiducial markers. The predicted 
target position is calculated from the 4D model, expressed by a quadratic equation involving 
two variables, the position and velocity of the IR markers. In the 4D-modeling phase, the 125 
peak-to-peak amplitude of the detected target motion (A) and the mean (μ) and standard 
deviation (SD) of the absolute difference between the detected and predicted target positions 
are automatically calculated along each axis (Fig. 2). During beam delivery, the 3D target 
position is calculated from the displacements of the IR markers using the 4D model, and then 
the corresponding tracking orientation is transferred continuously to the gimbaled x-ray head. 130 
The predicted target position can also be monitored visually in real time at a minimum interval 
of 1 s on intra-fractional fluoroscopic images. 
 
II. B. Dosimetric and positional verification of IR Tracking 
For the clinical application of IR Tracking, the following verifications were 135 
performed:  
(1) Dosimetric and positional verification of 1D sinusoidal patterns with perfect 
correlation between the target and IR marker motions, using a motor-driven base. 
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(2) Positional verification of 1D sinusoidal patterns with miscorrelation between the 
target and IR marker motions, using a dynamic anthropomorphic thorax phantom.  140 
(3) Positional verification of 3D target and 1D surrogate motions, based on the patient’s 
respiration, using a four-axis moving phantom. 
 
II. B. 1. Dosimetric and positional verification of IR Tracking for 1D sinusoidal patterns 
Figure 3(a) shows a photograph of the experimental system for the dosimetric and 145 
positional verification of IR Tracking. The IR markers were moved synchronously with the 1D 
motor-driven base (QUASAR, Modus Medical Devices Inc., London, ON, Canada) in the 
anteroposterior (AP) direction. 
Dosimetric verification was performed using EDR2 film (Kodak, Rochester, NY, 
USA), placed at a depth of 100 mm (1000 mm source-to-isocenter distance) in 150 
water-equivalent phantoms on the motor-driven base. Four pinholes were made on the film to 
identify the isocenter. The EDR2 film (Kodak, Rochester, NY, USA) was irradiated with a 
field size of 50×50 mm2 under stationary, tracking, and non-tracking states for 1D sinusoidal 
patterns (A: 20-40 mm, breathing period [T]: 2-4 s) in the craniocaudal (CC) direction. In total, 
seven irradiated films were scanned in the same orientation (ES-10000G; Epson Corp., Nagano, 155 
Japan) with a resolution of 150 dpi in 16-bit grayscale with a 12-h postexposure period. All 
films were analyzed using commercially available radiation dosimetry software (DD system, 
ver. 9.4; R’Tech Inc., Tokyo, Japan). Differences in the width of the 95% dose profile between 
stationary and moving conditions ( 95DE ) were calculated. 
Additionally, positional verification was performed using a laser displacement gauge 160 
(IL-300; Keyence Corp., Osaka, Japan), with a positional accuracy of 0.05 mm. The laser 
displacement gauge was used for independent validation of IR Tracking and was not part of the 
Vero4DRT IR Tracking system. In the experiment, the target position was measured with the 
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laser displacement gauge every 10 ms for independent validation, and the laser displacement 
signals were sent to a system controller for synchronization of the data recording. The 165 
Vero4DRT records IR Tracking logs into the system controller every 5 ms. Based on the 
recorded tracking orientation of the gimbaled x-ray head, the tracked position of the target on 
the isocenter plane was calculated as follows:  
),tan(960 Tt θy −=  
where yt is the tracked position of the target in the CC direction, Tθ  is the tilt angle of the 170 
gimbaled x-ray head, and 960 mm is the distance from the rotation center of the gimbals to the 
isocenter. The positional tracking error (EP) was defined as EP = yt − yml, where yml is the 
phantom position in the CC direction, measured with the laser displacement gauge. The 95th 
percentile of the EP ( 95PE ) was then calculated. 
 175 
II. B. 2. Positional verification of IR Tracking for 1D phase-shifted sinusoidal patterns 
Figure 3(b) shows a photograph of the experimental system for the positional 
verification of IR Tracking for the 1D phase-shifted sinusoidal patterns (A: 20 mm, T: 4 s, 
phase shift [τ]: 0.2-2 s):  





where yp(t) is the phantom position in the CC direction and zs(t) is the displacement of the IR 
markers in the AP direction. Positional accuracy was evaluated using the dynamic 
anthropomorphic thorax phantom (CIRS Inc., Norfolk, VA) with a high precision (0.1 mm) 
laser displacement gauge. 95PE  was estimated as described in Section II. B. 1. 185 
 
II. B. 3. Positional verification of IR Tracking for 3D respiratory patterns 
Figure 3(c) shows a photograph of the experimental system for the positional 
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verification of IR Tracking with the 3D respiratory patterns acquired from six lung cancer 
patients. IR markers for measurement using Polaris Spectra (Northern Digital Inc., Waterloo, 190 
Ontario, Canada) and fiducial markers for measurement using the gantry-mounted orthogonal 
kV x-ray imaging subsystem were attached to the surface of a cubic phantom. The Polaris 
Spectra was used for independent validation of IR Tracking and was not part of the Vero4DRT 
IR Tracking system. Then, the cubic phantom was placed firmly on the 3D-driven base of a 
four-axis moving phantom, which moved three-dimensionally, based on the acquired internal 195 
target motions. Other IR markers for IR Tracking were also placed on the 1D driven base of the 
four-axis moving phantom, which moved based on the acquired IR marker motions in the AP 
direction only. The four-axis moving phantom was able to reproduce patient respiratory 
motions with high precision (0.1 mm).23 The positions of the IR markers for measurement 
(PmP[xmP, ymP, zmP]) and fiducial markers for measurement (PmX[xmX, ymX, zmX]) were measured 200 
with the Polaris Spectra, with a measurement accuracy of 0.3 mm, every 16.7 ms, and by the 
gantry-mounted orthogonal kV x-ray imaging subsystem every 1 s, respectively. In the present 
study, these positional data were recorded synchronously, based on the exposer signal of the 
orthogonal kV x-ray imaging subsystem. 
First, the detection accuracy of the gantry-mounted orthogonal kV x-ray imaging 205 
subsystem was evaluated in the stationary condition using the treatment couch, with a 
positional accuracy of 0.01 mm. Second, in total, 742 comparisons between PmP and PmX were 
made to evaluate the detection accuracy of the gantry-mounted orthogonal kV x-ray imaging 
subsystem in the moving condition using the Polaris Spectra and the four-axis moving 
phantom. 210 
To investigate the tracking accuracy in each direction, positional verification was 
performed at gantry angles of 0° and 90°. Based on the recorded tracking orientation of the 
gimbaled x-ray head, the tracked position of the target was estimated on the perpendicular 
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plane to the home gimbal-axis at the measured target position.10 At a gantry angle of 0°, the 
tracked position of the target was calculated as follows: 215 
),tan()960( PmXt zx θ−=  
),tan()960( TmXt zy θ−−=  
where xt is the tracked position of the target in the lateral (LR) direction, Pθ  is the pan angle 
of the gimbaled x-ray head, yt is the tracked position of the target in the CC direction, and Tθ  
is the tilt angle of the gimbaled x-ray head. At a gantry angle of 0°, the tracked position of the 220 
target at the gantry angle of 90° was calculated as follows: 
),tan()960( TmXt xy θ−−=  
),tan()960( PmXt xz θ−=  
where zt is the tracked position of the target in the AP direction. The EP was defined as 



































PE  was estimated as described in Sections II. B. 1. and II. B. 2. 
 
 
III. RESULTS AND DISCUSSION 230 
III. A. Dosimetric and positional verification of IR Tracking for 1D sinusoidal patterns 
Figure 4(a) shows dose profiles of a 50×50-mm2 field under stationary, tracking, and 
non-tracking states for the sinusoidal patterns with (A, T) = (40 mm, 2 s). The blurred effect, 
due to phantom motion, was reduced substantially by IR Tracking, comparable with previous 
results.9 Figure 4(b) shows variations in the tracked and measured positions of the target for the 235 
sinusoidal patterns with (A, T) = (40 mm, 2 s) in the CC direction. Even for the severe motion 
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pattern, the gimbaled x-ray head tracked the target in real time with high accuracy. 
Table I summarizes μ + 2SD of the absolute 4D-modeling error ( SDDME
2μ
4
+ ), 95DE , and 
95





+  was calculated from the μ and SD displayed on the 
screen of the Vero4DRT in the 4D-modeling phase. Under conditions of perfect correlation 240 
between the target and IR marker motions, SDDME
2μ
4
+  ranged from 1.4 to 1.9 mm. 95DE  ranged 
from 11.2 to 29.6 mm in the non-tracking state; however, these values were reduced by 0.0 to 
1.2 mm in the tracking state. IR Tracking reduced blurring dramatically and produced a 
dose-profile slope similar to that of the stationary state. Additionally, the measured and tracked 
positions of the target were consistent with each other. 95PE  ranged from 1.3 to 1.8 mm in the 245 
tracking state and from 9.9 to 19.9 mm in the non-tracking state, and 95PE  in the tracking state 
was similar to SDDME
2μ
4
+ . As shown in Table I, 95DE  was much smaller than twice 
95
PE  because 
the randomized dose errors were partially cancelled out at the field edge; thus, assessment of 
95
PE  represents an alternative safety indicator in terms of determining whether the internal 
margin for IR Tracking is adequate in clinical practice. 250 
 
III. B. Positional verification of IR Tracking for 1D phase-shifted sinusoidal patterns 
Table II summarizes the absolute correlation coefficient between the target and IR 











+  and 95PE  increased linearly, from 0.4 to 3.0 mm (R = -0.98) and from 0.5 255 





+  and 95PE  (R = 0.99). In the 4D-modeling process, the 4D model was created to 
minimize residual errors between the predicted and detected target positions. Thus, the 
relationship between 95PE  and 
95
DE  will be almost equivalent even in the presence of a 
phase shift. 260 
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III. C. Positional verification of IR Tracking for 3D respiratory patterns  
The root mean squares (RMSs) of the detection accuracy of the gantry-mounted 
orthogonal kV x-ray imaging subsystem under the stationary condition were 0.07, 0.04, and 
0.03 mm in the LR, CC, and AP directions, respectively. The RMSs of the detection accuracy 265 
of the gantry-mounted orthogonal kV x-ray imaging subsystem under the moving condition 
were 0.14, 0.39, and 0.15 mm in the LR, CC, and AP directions, respectively. These results 
show that the gantry-mounted orthogonal kV x-ray imaging subsystem of the Vero4DRT had 
high detection accuracy, even for moving targets. 
Figure 5 shows variations in the target position along the CC direction for the 270 
respiratory pattern of the first patient who underwent IR Tracking (Patient No. 3). 95PE  was 
1.6 mm for this patient. 
Table III summarizes SDDME
2μ
4
+  and 95PE  for respiratory patterns. A strong negative 





+  was observed in each direction [(LR, CC, AP) = 
(-0.88, -0.90, -0.92)]. A strong positive correlation was also found between SDDME
2μ
4
+  and 95PE  in 275 





+ . Figure 6 shows accumulated probability histograms (a) as a function of the positional 
tracking errors and (b) as a function of the tracking efficiency, defined as the AEP
952 , in each 
direction at gantry angles of 0° and 90°. The positional tracking errors were larger in the CC 
direction than in the other directions [Fig. 6(a)]. However, the tracking efficiencies were the 280 
highest in the CC direction [Fig. 6(b)]. Lower tracking efficiencies in other directions than in 
the CC direction were caused by the small || targetIRR  (Table III). Additionally, tracking accuracy 
was not degraded by gantry rotation, even at an angle of 90°. 
Pepin et al. suggested that a dry-run treatment session prior to treatment planning is 
required to determine patient-specific margins covering positional tracking error during the 285 
treatment when performing DTT with the Synchrony Respiratory Tracking System.22 The 
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present study revealed that positional tracking errors were near-identical to 4D-modeling errors, 
derived from miscorrelation between the target and abdominal wall motions, such as the phase 
shift or irregular respiration. Thus, users of the Vero4DRT should evaluate the accuracy of the 
4D model in a dry-run treatment session, and the following should then be discussed, based on 290 
the acquired 4D-modeling accuracy: (1) adding margins to compensate for 4D-modeling errors 
and (2) conducting respiratory coaching to minimize the phase shift.24  
The correlation between tumor and surrogate motion is known to change from 
treatment planning to treatment delivery.3,25,26 The change in correlation may cause additional 
tracking errors in IR Tracking; thus, additional margins to compensate for these uncertainties 295 
are required, and confirmation of whether the 4D-modeling errors for each fraction are within 
the margin derived from 4D-modeling errors at treatment planning is recommended. 
Additionally, Malinowski et al. reported that an extended treatment time can lead to 
miscorrelation between the external surrogate and internal tumor motion, due to baseline 
drift.27 During irradiation, we can estimate visually the tracking errors in real time from the 300 
implanted fiducial markers – or the tumor itself – on the intra-fractional fluoroscopic images. 
When these positions deviate systematically from those predicted, due to baseline drift or 
changes in respiration, remodeling of the 4D model during a treatment fraction is required to 
perform IR Tracking safely. 
 305 
IV. CONCLUSIONS 
We verified the dosimetric and positional accuracy of IR Tracking and confirmed its 
feasibility in clinical practice. IR Tracking reduced substantially motion-induced marginal 
blurring in the dose distribution. Additionally, positional tracking errors correlated strongly 
with 4D-modeling errors, which resulted from miscorrelations between target and IR marker 310 
motions. Thus, the accuracy of the 4D model must be verified before treatment, and margins 
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are required to compensate for 4D-modeling errors. 
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FIGURE LEGENDS 
Figure 1. Schematic diagram of the Vero4DRT. 
 
Figure 2. Schematic diagram of infrared (IR) marker-based dynamic tumor-tracking 415 
irradiation (IR Tracking). In the 4D-modeling phase, the mean and standard deviation of the 
absolute 4D-modeling error, as well as the peak-to-peak amplitude of the target motion, are 
shown on the screen of the Vero4DRT. The right four groups of waves, from top to bottom, 
show variations in the IR markers’ positions in the anteroposterior (AP) direction and the 
target positions in the lateral (LR), craniocaudal (CC), and AP directions, respectively. In the 420 
graphs of the target position, dark-colored waves show the detected target position and 
light-colored waves show the predicted target position. During beam delivery, the future 3D 
target position is calculated from the displacements of the IR markers using the 4D model, 
and then the corresponding tracking orientation is transferred continuously to the gimbaled 
x-ray head. 425 
 
Figure 3. Photograph of the experimental system for (a) dosimetric and positional 
verification of infrared (IR) marker-based dynamic tumor-tracking (IR Tracking) of 1D 
sinusoidal patterns, (b) positional verification of 1D phase-shifted sinusoidal patterns, and (c) 
positional verification of the 3D respiratory patterns of six patients with lung cancer. 430 
 
Figure 4. (a) Dose profile of a 50×50 mm2 field under stationary, tracking, and non-tracking 
states and (b) variations in the tracked and measured positions of the target for the sinusoidal 
pattern with a peak-to-peak amplitude of 40 mm and breathing period of 2 s. 
 435 
Figure 5. Variations in the target position along the craniocaudal (CC) direction for the 
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respiratory pattern of the first patient who underwent IR Tracking (Patient No. 3). Square 
symbols indicate the detected positions of the target, solid lines with round symbols indicate 
the tracked positions of the target, and dotted lines show positional tracking errors. 
 440 
Figure 6. Accumulated probability histogram (a) as a function of the 95th percentile of the 
positional tracking error ( 95PE ) and (b) as a function of the tracking efficiency, defined as the 
ratio of twice the 95th percentile of the positional tracking error ( 95PE ) to the peak-to-peak 
amplitude (A), in the lateral (LR), craniocaudal (CC), and anteroposterior (AP) directions 
under gantry angles of 0° (G0deg) and 90° (G90deg). 445 






+μ , 95DE , and 
95
PE  under non-tracking and tracking states for sinusoidal patterns. 
Case A [mm] T [s] SDDME
2
4
+μ  [mm] 
Non-tracking Tracking 
95
DE  [mm] 
95
PE  [mm] 
95
DE  [mm] 
95
PE  [mm] 
1 40 2 1.8 29.6 19.9 1.2 1.8 
2 40 4 1.9 29.4 19.9 0.2 1.8 
3 20 2 1.4 11.2 9.9 0.0 1.3 
Abbreviations: μ = mean; SD = standard deviation; SDDME
2
4
+μ  = μ+2SD of the absolute 4D-modeling error; 95DE  = differences in the 
width of the 95% dose profile between stationary and moving conditions; 95PE  = 95
th percentile of the positional tracking error; 
A = peak-to-peak amplitude; T = breathing period. 450 
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PE  of phase-shifted sinusoidal patterns with a peak-to-peak amplitude of 20 mm and 
breathing period of 4 s. 





+μ  [mm] 95PE  [mm] 
1 0.0 1.00 0.4 0.6 
2 0.2 0.95 0.6 0.7 
3 0.4 0.82 1.4 1.4 
4 1.0 0.10 3.0 2.2 
5 2.0 1.00 0.4 0.5 




+  = μ+2SD of the absolute 4D-modeling error; 95PE  = 95
th percentile of the positional tracking error; τ = phase 
shift. 
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+μ  [mm] 95PE  [mm] 
LR CC AP LR CC AP LR CC AP LR CC AP 
1 2.4 13.9 7.5 3.6 0.78 0.91 0.01 0.6 3.0 3.2 0.7 2.9 2.6 
2 2.0 35.2 5.6 5.5 0.41 0.99 0.93 1.0 3.3 1.4 0.9 3.6 1.2 
3 1.7 11.9 1.5 3.4 0.98 0.98 0.26 0.2 1.3 0.5 0.2 1.5 0.6 
4 4.2 17.0 3.4 3.5 0.92 0.99 0.93 1.2 2.5 0.4 1.2 2.6 0.5 
5 1.7 21.2 3.3 3.4 0.97 0.98 0.92 0.3 2.4 0.5 0.3 2.4 0.6 
6 0.7 10.7 2.6 3.1 0.17 0.99 0.60 0.3 1.0 0.7 0.3 1.0 0.8 




+  = μ+2SD of the absolute 4D-modeling error; 95PE  = 95
th percentiles of the positional tracking error; 
A = peak-to-peak amplitude; T = breathing period; LR = lateral direction; CC = craniocaudal direction; AP = anteroposterior 
direction. 










